Short-Term Effects of COVID-19-Related Deferral of Intravitreal Injection Visits

被引:18
作者
Ashkenazy, Noy [1 ]
Goduni, Lediana [1 ]
Smiddy, William E. [1 ]
机构
[1] Univ Miami, Miller Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, Miami, FL 33136 USA
关键词
COVID-19; SARS-CoV-2; pandemic; retinal vascular diseases; anti-vascular endothelial growth factor; treatment outcomes;
D O I
10.2147/OPTH.S296345
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To determine secondary effects of the mandated COVID-19 pandemic closure period for elective treatment on non-elective, injection-based retina care and outcomes. Patients and Methods: In this cross-sectional, retrospective analysis of a single-provider outpatient clinic across multiple satellites, consecutive patients returning for intravitreal injections (IVIs) of anti-vascular endothelial growth factor or corticosteroids were identified as "delayed" or "undelayed" during a six-week study interval during the COVID-19 pandemic that closely following a mandated period of prohibited elective encounters. A "delayed" encounter was defined as having a follow-up interval exceeding 33% of the recommended cycle. Patients seen for IVIs during the corresponding six-week interval a year previously were identified for study as pre-COVID-19 controls. Main outcome measures included best-corrected visual acuity (BCVA) and optical coherence tomography (OCT) assessment based on findings of intraretinal or subretinal fluid consistent with new or recurrent neovascular events. Results: The study included 183 eyes of 144 patients who underwent IVI-based care from June 18, 2020, through August 7, 2020, compared to 193 eyes of 154 patients injected during the corresponding interval 1 year before. There were 62 eyes of 46 patients seen in the study period later than scheduled (among 144 patients of 183 eyes in total), which represented a larger proportion of delayed patients compared to the previous year (31.9% vs. 14.9%, p<0.0005). Considering the patterns from the control group, the attributed delay due to COVID-19 was 15.0% of patients. The delayed return eyes had a greater decline in BCVA (3 letters), higher rates of worsened OCT results (48%), and prompted reduction in previously prescribed injection intervals (p<0.02). Conclusion: The unintended consequence of delayed care of patients on established care regimens should be anticipated, and mitigate strategies considered if similar restrictions are mandated in the future.
引用
收藏
页码:413 / 417
页数:5
相关论文
共 15 条
[1]  
AAO, 2020, LIST URG EM OPHTH PR
[2]  
ASRS, 2020, ASRS REL GUID HELP R
[3]   Impact of COVID-19 on outpatient visits and intravitreal treatments in a referral retina unit: let's be ready for a plausible "rebound effect" [J].
Borrelli, Enrico ;
Grosso, Domenico ;
Vella, Giovanna ;
Sacconi, Riccardo ;
Querques, Lea ;
Zucchiatti, Ilaria ;
Prascina, Francesco ;
Bandello, Francesco ;
Querques, Giuseppe .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2020, 258 (12) :2655-2660
[4]   Intravitreal injections during COVID-19 outbreak: Real-world experience from an Italian tertiary referral center [J].
Carnevali, Adriano ;
Giannaccare, Giuseppe ;
Gatti, Valentina ;
Scuteri, Gianfranco ;
Randazzo, Giorgio ;
Scorcia, Vincenzo .
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2021, 31 (01) :10-12
[5]   Loss to Follow-Up in Patients With Retinal Vein Occlusion Undergoing Intravitreal Anti-VEGF Injections [J].
Gao, Xinxiao ;
Obeid, Anthony ;
Adam, Murtaza K. ;
Hyman, Leslie ;
Ho, Allen C. ;
Hsu, Jason .
OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2019, 50 (03) :159-166
[6]   Vision Outcomes Following Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical Practice [J].
Holekamp, Nancy M. ;
Campbell, Joanna ;
Almony, Arghavan ;
Ingraham, Herbert ;
Marks, Steven ;
Chandwani, Hitesh ;
Cole, Ashley L. ;
Kiss, Szilard .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2018, 191 :83-91
[7]  
Hsu J, 2020, RET SOC 2020 VR 53 A
[8]  
Khan M, 2020, OPHTHALMOL RETINA, V22
[9]   Potential Indirect Effects of the COVID-19 Pandemic on Use of Emergency Departments for Acute Life-Threatening Conditions - United States, January-May 2020 [J].
Lange, Samantha J. ;
Ritchey, Matthew D. ;
Goodman, Alyson B. ;
Dias, Taylor ;
Twentyman, Evelyn ;
Fuld, Jennifer ;
Schieve, Laura A. ;
Imperatore, Giuseppina ;
Benoit, Stephen R. ;
Kite-Powell, Aaron ;
Stein, Zachary ;
Peacock, Georgina ;
Dowling, Nicole F. ;
Briss, Peter A. ;
Hacker, Karen ;
Gundlapalli, Adi, V ;
Yang, Quanhe .
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (25) :795-800
[10]   Loss to Follow-up Among Patients With Neovascular Age-Related Macular Degeneration Who Received Intravitreal Anti-Vascular Endothelial Growth Factor Injections [J].
Obeid, Anthony ;
Gao, Xinxiao ;
Ali, Ferhina S. ;
Aderman, Christopher M. ;
Shahlaee, Abtin ;
Adam, Murtaza K. ;
Kasi, Sundeep K. ;
Hyman, Leslie ;
Ho, Allen C. ;
Hsu, Jason .
JAMA OPHTHALMOLOGY, 2018, 136 (11) :1251-1259